Abstract Background Transcatheter aortic valve implantation (TAVI) is a minimally invasive surgery. However, there is a risk of surgical manipulation
Transcatheter heart valves technologies
Abstract Background Transcatheter aortic valve implantation (TAVI) is a minimally invasive surgery. However, there is a risk of surgical manipulation
Transcatheter heart valves technologies
Abstract Aims Characterize the impact of residual tricuspid regurgitation (TR) on right ventricle (RV) remodeling and clinical outcomes after transcatheter
Transcatheter heart valves technologies
Abstract Background Studies have found statin treatment to be associated with improved 1-year survival after transcatheter aortic valve implantation (TAVI),
Transcatheter heart valves technologies
Abstract Background Transcatheter aortic valve replacement (TAVR) is as an alternative treatment to surgical AVR, but the long‐term outcomes of
Transcatheter heart valves technologies
Abstract Objective To assess gender, ethnicity, and deprivation-based differences in provision of aortic valve replacement (AVR) in England for adults
Transcatheter heart valves technologies
Abstract Background Patient‐reported outcome measures have been shown to have important prognostic value after various cardiac interventions. We assessed the
Transcatheter heart valves technologies
Abstract Background In TAVI procedural stroke is one of the most feared complications and for this reason also extensively studied.
Transcatheter heart valves technologies
Abstract Background Transcatheter pulmonary valve replacement (TPVR) in patients with a congenital or acquired abnormality resulting in enlarged right ventricular
Transcatheter heart valves technologies
Abstract Introduction This study aimed to investigate the mechanisms and clinical implications of mitral regurgitation (MR) in patients with severe